INS and Hyperglycemia: Pre-treatment of diabetic rats with vildagliptin significantly reduced hyperglycaemia (p<0.001) and increased plasma insulin level (p<0.001) and decreased HOMA1-IR index (p<0.05) comparing to the diabetic group (Table 2).